Jun 30, 2011

United Therapeutics Q2 2011 Earnings Report

Total Revenue
$181M
Previous year: $137M
+31.4%
EPS
$1.28
Previous year: $0.67
+91.0%
Gross Profit
$163M
Previous year: $121M
+34.6%
Cash and Equivalents
$321M
Previous year: $285M
+12.5%
Free Cash Flow
$52M
Previous year: $32.5M
+60.1%
Total Assets
$1.58B
Previous year: $1.19B
+32.9%

United Therapeutics

United Therapeutics